NPPA hikes 21 formulations’ prices by 50%

The National Pharmaceuticals Pricing Authority (NPPA) invoked paragraph 19 of the Drug Prices Control Order to grant a 50% increase in the prices of 21 drug formulations. With the cost of raw material imported from China increasing 50-200%, pharma groups had approached the government to invoke extraordinary powers and increase the prices of drugs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2RQyisg
via IFTTT